News – Page 120 – Endpoints News

In bid to save cash, Grail says it will cut 350 jobs and focus on multi-cancer test

9 months ago

To get back to growth, Illumina CEO says it's simplifying DNA sequencing and analysis

9 months ago

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

9 months ago

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Past and present FDA adcomm members weigh in on potential reforms

9 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

9 months ago

Rivus posts a win for its experimental obesity drug in heart failure patients

9 months ago

Federal judge rules against Novartis in Entresto generic lawsuit

9 months ago

IRA price negotiation results to be released Thursday — report

9 months ago

Kyverna shares safety data for CAR-T; Evotec gets $75M milestone

9 months ago

CSL Behring says uptake of hemophilia B gene therapy slower than expected

9 months ago

Galderma wins FDA approval for IL-31 drug in chronic skin disease

9 months ago

Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics

9 months ago

Why a new health tech venture firm is investing only in founders with a healthcare background

9 months ago

Lawmakers renew calls for government to finalize march-in guidance

9 months ago

J&J receives support for $6.5B talc settlement — report

9 months ago

Pressure from anti-China legislation begins to ripple through biopharma

9 months ago

Legend continues Carvykti factory builds to cement CAR-T territory with J&J

9 months ago

Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues

9 months ago

Corrected: Novo Nordisk to file in EU and China with late-phase insulin plus semaglutide data – but not yet in the ...

9 months ago

Three papers on MDMA are retracted by medical journal, just a day after Lykos' FDA rejection

9 months ago

Tenax raises $100M; Sanofi buys into MeiraGTx

9 months ago

Ascendis scores FDA approval for hypoparathyroidism candidate to replace Takeda's pulled drug

9 months ago

Pfizer touts strength of RSV vaccine in subgroup of younger immunocompromised patients

9 months ago

First page Previous page 117 118 119120121 122 123 Next page Last page